Understanding these contraindications is essential for healthcare providers and patients to ensure safe and appropriate use of this compounded medication
Please consult your physician before beginning any treatment or therapy program
Each vial combines four active ingredients - methionine, inositol, choline, and vitamin B12 (cyanocobalamin) - to support fat metabolism, liver function, and sustained energy levels during caloric restriction
Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients